CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 259 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$40,529,000
+59.8%
436,072
+2.4%
0.01%
+50.0%
Q3 2021$25,367,000
-11.5%
425,977
+1.3%
0.01%
-20.0%
Q2 2021$28,666,000
+1.5%
420,316
+3.3%
0.01%0.0%
Q1 2021$28,239,000
-4.3%
406,955
+6.0%
0.01%
-16.7%
Q4 2020$29,497,000
+4.6%
383,925
+1.8%
0.01%
-7.7%
Q3 2020$28,208,000
+20.2%
377,157
+1.2%
0.01%
+18.2%
Q2 2020$23,473,000
+75.9%
372,868
+17.4%
0.01%
+37.5%
Q1 2020$13,343,000
-16.7%
317,682
-9.9%
0.01%
-11.1%
Q4 2019$16,022,000
-0.6%
352,744
+0.2%
0.01%
-10.0%
Q3 2019$16,111,000
-18.0%
351,978
+5.0%
0.01%
-16.7%
Q2 2019$19,656,000
+54.1%
335,245
+17.9%
0.01%
+50.0%
Q1 2019$12,753,000
+20.8%
284,467
+5.0%
0.01%0.0%
Q4 2018$10,554,000
-15.9%
270,962
-0.6%
0.01%0.0%
Q3 2018$12,551,000
+12.2%
272,715
+6.3%
0.01%0.0%
Q2 2018$11,190,000
+30.0%
256,650
+17.8%
0.01%
+14.3%
Q1 2018$8,608,000
+21.2%
217,910
+4.2%
0.01%
+16.7%
Q4 2017$7,103,000
+55.3%
209,085
+16.6%
0.01%
+50.0%
Q3 2017$4,574,000
+106.2%
179,353
+36.4%
0.00%
+100.0%
Q2 2017$2,218,000131,4650.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 4,190,000$321,918,0005.54%
Prosight Management, LP 145,700$11,194,0005.17%
Integral Health Asset Management, LLC 200,000$15,366,0004.57%
Copernicus Capital Management, LLC 3,740$287,0004.47%
GREAT POINT PARTNERS LLC 345,120$26,516,0004.31%
Asymmetry Capital Management, L.P. 101,245$7,779,0003.55%
First Light Asset Management, LLC 321,967$24,737,0001.83%
DAFNA Capital Management LLC 76,815$5,902,0001.76%
SECTORAL ASSET MANAGEMENT INC 320,059$24,590,0001.73%
Nicholas Investment Partners, LP 276,633$21,254,0001.64%
View complete list of ARENA PHARMACEUTICALS INC shareholders